FI965032A - Interleukiini-5-spesifisiä yhdistelmä-vasta-aineita - Google Patents
Interleukiini-5-spesifisiä yhdistelmä-vasta-aineita Download PDFInfo
- Publication number
- FI965032A FI965032A FI965032A FI965032A FI965032A FI 965032 A FI965032 A FI 965032A FI 965032 A FI965032 A FI 965032A FI 965032 A FI965032 A FI 965032A FI 965032 A FI965032 A FI 965032A
- Authority
- FI
- Finland
- Prior art keywords
- interleukin
- recombinant antibodies
- specific recombinant
- specific
- heavy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9412230A GB9412230D0 (en) | 1994-06-17 | 1994-06-17 | Interleukin-5 specific recombiant antibodies |
PCT/GB1995/001411 WO1995035375A1 (en) | 1994-06-17 | 1995-06-16 | Interleukin-5 specific recombinant antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
FI965032A0 FI965032A0 (fi) | 1996-12-16 |
FI965032A true FI965032A (fi) | 1996-12-16 |
Family
ID=10756925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI965032A FI965032A (fi) | 1994-06-17 | 1996-12-16 | Interleukiini-5-spesifisiä yhdistelmä-vasta-aineita |
Country Status (18)
Country | Link |
---|---|
US (3) | US5998586A (fi) |
EP (1) | EP0765392B1 (fi) |
JP (1) | JP3973682B2 (fi) |
AT (1) | ATE264389T1 (fi) |
AU (1) | AU694783B2 (fi) |
CA (1) | CA2192543C (fi) |
CZ (1) | CZ292295B6 (fi) |
DE (1) | DE69532889T2 (fi) |
ES (1) | ES2218546T3 (fi) |
FI (1) | FI965032A (fi) |
GB (1) | GB9412230D0 (fi) |
HU (1) | HU221641B1 (fi) |
IL (1) | IL114179A (fi) |
NO (1) | NO964808L (fi) |
NZ (1) | NZ287927A (fi) |
SK (1) | SK282625B6 (fi) |
WO (1) | WO1995035375A1 (fi) |
ZA (1) | ZA954990B (fi) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39548E1 (en) | 1994-06-17 | 2007-04-03 | Celltech R&D Limited | Interleukin-5 specific recombinant antibodies |
GB9412230D0 (en) * | 1994-06-17 | 1994-08-10 | Celltech Ltd | Interleukin-5 specific recombiant antibodies |
AU708951B2 (en) * | 1994-12-23 | 1999-08-19 | Smithkline Beecham Corporation | Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
US5693323A (en) * | 1994-12-23 | 1997-12-02 | Smithkline Beecham Corporation | Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
US7399837B2 (en) | 1995-12-22 | 2008-07-15 | Smithkline Beecham Corporation | Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
JP2002543098A (ja) * | 1999-04-23 | 2002-12-17 | ファーメクサ エイ/エス | Il5活性のダウン−レギュレート方法 |
US8133978B2 (en) | 2006-05-25 | 2012-03-13 | Glaxo Group Limited | Humanised anti-interleukin-18 antibody |
CA2719786A1 (en) | 2008-03-28 | 2009-10-01 | Glaxosmithkline Llc | Methods of treatment |
WO2010042562A2 (en) | 2008-10-06 | 2010-04-15 | Minerva Biotechnologies Corporation | Muc1* antibodies |
EP3578205A1 (en) | 2010-08-06 | 2019-12-11 | ModernaTX, Inc. | A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof |
AU2011308496A1 (en) | 2010-10-01 | 2013-05-02 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
KR101941514B1 (ko) * | 2010-12-22 | 2019-01-23 | 테바 파마슈티컬즈 오스트레일리아 피티와이 엘티디 | 개선된 반감기를 가지는 변형된 항체 |
JP2014511687A (ja) | 2011-03-31 | 2014-05-19 | モデルナ セラピューティクス インコーポレイテッド | 工学操作された核酸の送達および製剤 |
US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
PT3682905T (pt) | 2011-10-03 | 2022-04-07 | Modernatx Inc | Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações |
HRP20220717T1 (hr) | 2011-12-16 | 2022-07-22 | Modernatx, Inc. | Modificirani pripravci mrna |
US9254311B2 (en) | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
EP2834358A4 (en) | 2012-04-02 | 2016-03-09 | Moderna Therapeutics Inc | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS |
US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
EP4074834A1 (en) | 2012-11-26 | 2022-10-19 | ModernaTX, Inc. | Terminally modified rna |
MX2015008534A (es) | 2012-12-26 | 2017-07-04 | Oncosynergy Inc | COMPOSICIONES DE ANTICUERPO ANTI-INTEGRINA ß1 Y METODOS DE USO DE LAS MISMAS. |
US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
EP3052106A4 (en) | 2013-09-30 | 2017-07-19 | ModernaTX, Inc. | Polynucleotides encoding immune modulating polypeptides |
EP3052521A1 (en) | 2013-10-03 | 2016-08-10 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor |
TW201613615A (en) | 2014-06-30 | 2016-04-16 | Academia Sinica | Antagonists for interleukin-17 receptor B (IL-17RB) and its ligand IL-17B for cancer therapy |
CA2976089A1 (en) | 2015-02-10 | 2016-08-18 | Minerva Biotechnologies Corporation | Humanized anti-muc1* antibodies |
AU2016311385C1 (en) | 2015-08-24 | 2019-08-22 | Glaxosmithkline Intellectual Property (No. 2) Limited | Biopharmaceutical compositions |
JP7295038B2 (ja) | 2017-06-06 | 2023-06-20 | グラクソスミスクライン エルエルシー | 小児患者のための生物薬剤組成物及び方法 |
EP3689906A4 (en) | 2017-09-29 | 2021-04-07 | Jiangsu Hengrui Medicine Co., Ltd. | IL-5 ANTIBODIES, ANTIGIBINDING FRAGMENT THEREOF, AND MEDICAL USES THEREOF |
CN109942706A (zh) * | 2017-12-21 | 2019-06-28 | 三生国健药业(上海)股份有限公司 | 结合人il-5的单克隆抗体、其制备方法和用途 |
CN113366016B (zh) * | 2018-12-12 | 2022-12-16 | 上海开拓者生物医药有限公司 | 抗人白细胞介素5(il-5)单克隆抗体及其应用 |
AU2020251627A1 (en) | 2019-03-29 | 2021-11-11 | Jiangsu Hengrui Medicine Co., Ltd. | Pharmaceutical composition containing antibody against IL-5 and use thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8308235D0 (en) * | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
GB8607679D0 (en) * | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
AU633034B2 (en) * | 1988-11-03 | 1993-01-21 | Schering Corporation | Method of preventing or reducing eosinophilia |
IL162181A (en) * | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
GB8928874D0 (en) * | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
WO1992008474A2 (en) * | 1990-11-20 | 1992-05-29 | The National Heart & Lung Institute | Treatment of lung diseases |
WO1993016184A1 (en) * | 1992-02-06 | 1993-08-19 | Schering Corporation | Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
AU684041B2 (en) * | 1992-02-19 | 1997-12-04 | Schering Corporation | Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
GB9412230D0 (en) * | 1994-06-17 | 1994-08-10 | Celltech Ltd | Interleukin-5 specific recombiant antibodies |
-
1994
- 1994-06-17 GB GB9412230A patent/GB9412230D0/en active Pending
-
1995
- 1995-06-06 US US08/470,139 patent/US5998586A/en not_active Ceased
- 1995-06-15 ZA ZA954990A patent/ZA954990B/xx unknown
- 1995-06-15 IL IL11417995A patent/IL114179A/xx not_active IP Right Cessation
- 1995-06-16 ES ES95921931T patent/ES2218546T3/es not_active Expired - Lifetime
- 1995-06-16 JP JP50181796A patent/JP3973682B2/ja not_active Expired - Lifetime
- 1995-06-16 CZ CZ19963712A patent/CZ292295B6/cs not_active IP Right Cessation
- 1995-06-16 DE DE69532889T patent/DE69532889T2/de not_active Expired - Lifetime
- 1995-06-16 HU HU9603183A patent/HU221641B1/hu not_active IP Right Cessation
- 1995-06-16 NZ NZ287927A patent/NZ287927A/en not_active IP Right Cessation
- 1995-06-16 EP EP95921931A patent/EP0765392B1/en not_active Expired - Lifetime
- 1995-06-16 SK SK1600-96A patent/SK282625B6/sk unknown
- 1995-06-16 WO PCT/GB1995/001411 patent/WO1995035375A1/en active IP Right Grant
- 1995-06-16 AU AU26803/95A patent/AU694783B2/en not_active Ceased
- 1995-06-16 AT AT95921931T patent/ATE264389T1/de not_active IP Right Cessation
- 1995-06-16 CA CA002192543A patent/CA2192543C/en not_active Expired - Lifetime
-
1996
- 1996-11-13 NO NO964808A patent/NO964808L/no unknown
- 1996-12-16 FI FI965032A patent/FI965032A/fi not_active Application Discontinuation
-
1999
- 1999-07-02 US US09/347,061 patent/US6316227B1/en not_active Expired - Lifetime
-
2001
- 2001-05-15 US US09/855,271 patent/US6734286B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6734286B2 (en) | 2004-05-11 |
CZ371296A3 (cs) | 1998-05-13 |
HU9603183D0 (en) | 1997-01-28 |
IL114179A (en) | 2001-08-26 |
GB9412230D0 (en) | 1994-08-10 |
EP0765392A1 (en) | 1997-04-02 |
NO964808L (no) | 1997-02-17 |
JP3973682B2 (ja) | 2007-09-12 |
ES2218546T3 (es) | 2004-11-16 |
US20020042089A1 (en) | 2002-04-11 |
ZA954990B (en) | 1996-12-17 |
CZ292295B6 (cs) | 2003-08-13 |
ATE264389T1 (de) | 2004-04-15 |
US5998586A (en) | 1999-12-07 |
DE69532889D1 (de) | 2004-05-19 |
NZ287927A (en) | 1998-07-28 |
WO1995035375A1 (en) | 1995-12-28 |
NO964808D0 (no) | 1996-11-13 |
HU221641B1 (hu) | 2002-12-28 |
HUT76672A (en) | 1997-10-28 |
SK282625B6 (sk) | 2002-10-08 |
SK160096A3 (en) | 1997-06-04 |
AU2680395A (en) | 1996-01-15 |
AU694783B2 (en) | 1998-07-30 |
FI965032A0 (fi) | 1996-12-16 |
US6316227B1 (en) | 2001-11-13 |
DE69532889T2 (de) | 2005-03-10 |
CA2192543C (en) | 2008-07-29 |
JPH10501697A (ja) | 1998-02-17 |
IL114179A0 (en) | 1995-10-31 |
EP0765392B1 (en) | 2004-04-14 |
CA2192543A1 (en) | 1995-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69532889D1 (de) | Interleukin-5-spezifische rekombinante antikörper | |
NO955167L (no) | Monoklonalt anti-V-integrin-antistoff | |
DK1516629T3 (da) | Humaniseret anti-CD-11a antibodies | |
DE69430060D1 (de) | Antikörper von rapamycinen mit offenem ring | |
DK0812333T3 (da) | Bispecifikt antistof, som er effektivt til behandling af B-cellelymfom og cellelinie | |
PT778891E (pt) | Anticorpo monoclonal recombinante anti-rhesus d (d7c2) | |
DE68914244D1 (de) | Monoklonaler Antikörper. | |
ES2106195T3 (es) | Anticuerpo igg aglicosilado anti cd3. | |
FI20070170A (fi) | Immunoglobuliinit, joista puuttuvat kevyet ketjut | |
AU628948B2 (en) | Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof | |
DE69828154D1 (de) | Anti-alphavbeta3 humanizierte monoklonale antikörper | |
DE69738312D1 (de) | Hepatitis b monoklonale antikörper | |
TR199800517A3 (tr) | Hümanize anti-hümen fas antikor. | |
BR9509902A (pt) | Fragmentos de anticorpos monoclonais apresentando atividade imunosupressante | |
DE59608073D1 (de) | Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid | |
NO890116D0 (no) | Monoklonale antistoffer. | |
DE69023717D1 (de) | Monoklonaler Antikörper. | |
DE69020315D1 (de) | Monoklonaler antikörper gegen c-reaktives protein. | |
ITRM920223A0 (it) | Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf. | |
NO985281D0 (no) | Monoklonalt antihumant MP52-antistoff | |
DE69324928D1 (de) | Monoklonaler antikörper | |
FI960566A0 (fi) | Monoklonaalinen vasta-aine, joka tunnistaa välisolun pinta-antigeenin | |
DE68916088D1 (de) | Anti-CPBII-monoklonaler Antikörper. | |
DE69320192D1 (de) | Monoklonaler antikörper gegen den extravillösen trophoblast |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |
Free format text: ABB OY |